Successful segmental small bowel allotransplantation in pigs

Area of Science:

• Surgical Innovation
• Transplantation Immunology
• Gastroenterology

Background:

• Small-bowel transplantation is a complex procedure with challenges in graft survival.
• Segmental intestinal allografts require specific surgical techniques for successful engraftment.
• Graft rejection and ischemia are significant hurdles in intestinal transplantation.

Purpose of the Study:

• To evaluate the feasibility and outcomes of a two-step segmental small-bowel transplantation in a porcine model.
• To assess the impact of immunosuppression on graft survival and rejection in segmental intestinal allografts.

Main Methods:

• A two-step surgical approach was used, involving initial enterostomized heterotopic allografts followed by interposition into intestinal continuity.
• Group I (n=6) received no immunosuppression, serving as a control.
• Group II (n=6) received a triple immunosuppression regimen (cyclosporine, azathioprine, methylprednisolone).

Main Results:

• Unsuppressed grafts in Group I had a mean survival of 17.7 days, with recipients surviving graft resection.
• In Group II, four recipients survived over 260 days with functioning grafts, while two succumbed to pneumonia.
• Graft rejection was identified as the primary cause of graft loss, with no observed cases of graft-versus-host disease (GVHD).

Conclusions:

• The two-step segmental small-bowel transplantation is a viable experimental model.
• Effective immunosuppression is crucial for overcoming rejection and achieving long-term graft survival in segmental intestinal transplantation.
• Further research is needed to optimize immunosuppressive strategies and mitigate rejection in intestinal transplantation.